In addition, transwell assays and wound healing assays demonstrated that the migration capability of Caco2 and HT29 cells in the SRSF9-overexpression group was markedly increased (Fig. 2F, H, I), suggesting that SRSF9 enhances the migration ability of CRC cells. The gene discussed is SRSF9; the disease is colorectal carcinoma.